EUVIMEDEUVIMED entdecken
Kommentar

Insulin Cost Caps, Trade-Offs, and Pharmacoequity in Diabetes

Utibe R Essien, Elena Byhoff

JAMA · 07.07.2026 · 336 (1) · 20

DOI: 10.1001/jama.2026.7544 ↗

Kurz gefasst

Kommentar in der Zeitschrift JAMA, erschienen am 07.07.2026. Verfasst von Utibe R Essien und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California, Los Angeles. Die Arbeit nennt 15 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine, University of California, Los Angeles.
  • Center for the Study of Healthcare Innovation, Implementation and Policy, VA Greater Los Angeles Healthcare System, Los Angeles, California.
  • Department of Medicine, University of Massachusetts Chan Medical School, Worcester.

Zitieren

APA

Essien, U. R., & Byhoff, E. (2026). Insulin Cost Caps, Trade-Offs, and Pharmacoequity in Diabetes. JAMA, 336(1), 20. https://doi.org/10.1001/jama.2026.7544

Vancouver

Essien UR, Byhoff E. Insulin Cost Caps, Trade-Offs, and Pharmacoequity in Diabetes. JAMA. 2026;336(1):20. doi:10.1001/jama.2026.7544

BibTeX
@article{Essien2026,
  author = {Essien, Utibe R and Byhoff, Elena},
  title = {Insulin Cost Caps, Trade-Offs, and Pharmacoequity in Diabetes},
  journal = {JAMA},
  year = {2026},
  volume = {336},
  number = {1},
  pages = {20},
  doi = {10.1001/jama.2026.7544}
}
Kostenlos starten →